[Elsevier]
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3
Authors£ºM.P. Goetz; M. Toi; J. Huober; J. Sohn; O. Tr¨¦dan; I.H. Park; M. Campone; S.-C. Chen; L.M. Manso; S. Paluch-Shimon; O.C. Freedman; J. O'Shaughnessy; X. Pivot; S.M. Tolaney; S. Hurvitz; A. Llombart-Cussac; V. Andr¨¦; A. Saha; G. van Hal; A. Shahir; H. Iwata; S.R.D. Johnston